Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
Cortes, J. E., Kim, D.-W., Pinilla-Ibarz, J., le Coutre, P. D., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., De; Angelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Lustgarten, S., Rivera, V. M., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T. P., Shah, N. P., Kantarjian, H. M.
American Society of Hematology (ASH)
Published 2018
American Society of Hematology (ASH)
Published 2018
Publication Date: |
2018-07-27
|
---|---|
Publisher: |
American Society of Hematology (ASH)
|
Print ISSN: |
0006-4971
|
Electronic ISSN: |
1528-0020
|
Topics: |
Biology
Medicine
|
Keywords: |
Myeloid Neoplasia, Lymphoid Neoplasia, Clinical Trials and Observations
|
Published by: |